CM
AGIO icon

Caption Management’s Agios Pharmaceuticals AGIO Stock Holding History

Caption Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
39,249
+26,900
+218% +$816K 0.01% 1005
2026
Q1 		$418K Sell
12,349
-81,137
-87% -$2.3M ﹤0.01% 1244
2025
Q4 		$2.54M Buy
93,486
+75,992
+434% +$2.67M 0.02% 754
2025
Q3 		$702K Buy
17,494
+494
+3% +$18.6K 0.01% 1215
2025
Q2 		$565K Sell
17,000
-53,000
-76% -$1.61M 0.01% 1081
2025
Q1 		$2.05M Sell
70,000
-34,404
-33% -$1.14M 0.02% 671
2024
Q4 		$3.43M Buy
104,404
+58,242
+126% +$2.74M 0.03% 505
2024
Q3 		$2.05M Buy
+46,162
New +$2.1M 0.03% 547
2023
Q2 		– Sell
-4,086
Closed -$102K – 1069
2023
Q1 		$93.9K Buy
+4,086
New +$109K ﹤0.01% 973
2022
Q2 		– Sell
-19,000
Closed -$552K – 1400
2022
Q1 		$552K Sell
19,000
-22,000
-54% -$672K 0.01% 1122
2021
Q4 		$1.35M Buy
+41,000
New +$1.65M 0.02% 931
2021
Q3 		– Sell
-19,000
Closed -$1.05M – 1468
2021
Q2 		$1.05M Sell
19,000
-59,000
-76% -$3.3M 0.01% 878
2021
Q1 		$4.03M Buy
78,000
+31,000
+66% +$1.54M 0.09% 305
2020
Q4 		$2.04M Buy
47,000
+16,000
+52% +$633K 0.05% 430
2020
Q3 		$1.09M Buy
31,000
+15,000
+94% +$657K 0.03% 595
2020
Q2 		$856K Sell
16,000
-26,000
-62% -$1.2M 0.03% 571
2020
Q1 		$1.49M Sell
42,000
-1,500
-3% -$69.3K 0.08% 314
2019
Q4 		$2.08M Sell
43,500
-71,100
-62% -$2.69M 0.07% 346
2019
Q3 		$3.71M Buy
+114,600
New +$4.74M 0.19% 143

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Caption Management's AGIO Position: Q2 2026 in Review

Caption Management increased its Agios Pharmaceuticals (AGIO) stake by 218% in Q2 2026, buying an estimated $816K and bringing the position to 39,249 shares worth $1.46M. The position accounts for 0.01% of the portfolio, ranked #1005.

Caption Management first reported a position in AGIO in Q3 2019 and has held it in 19 quarters since. The position peaked at $4.03M in Q1 2021. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Caption Management held 39,249 shares of Agios Pharmaceuticals worth $1.46M as of Q2 2026.
  • Caption Management bought 26,900 Agios Pharmaceuticals shares in Q2 2026, an estimated $816K.
  • Agios Pharmaceuticals made up 0.01% of Caption Management's portfolio in Q2 2026, its #1005 holding.
  • Caption Management first reported a position in Agios Pharmaceuticals in Q3 2019 and has held it in 19 quarters since.
  • Caption Management's Agios Pharmaceuticals position peaked at $4.03M in Q1 2021.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.